Bloomberg
Covid-19 Antibody Treatments Need More Work: Johns Hopkins
Jul.22 -- Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses understanding how antibody production works in the fight against Covid-19. She speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance."...
Bloomberg
Moderna Vaccine Shows Signs It Can Stop Virus From Replicating, CEO Says
May.18 -- An experimental vaccine from the U.S. biotechnology company Moderna Inc. showed signs that it can create an immune-system response to fend off the new coronavirus, offering tentative hopes in the global effort to combat the...
Curated Video
Pharmacies Told To Give 4th COVID Shots To Immunocompromised Patients
The directive comes after some pharmacies turned away immunocompromised patients seeking their fourth COVID shot.
Bloomberg
Moderna Makes Twice as Many Antibodies as Pfizer: Study
According to a study, Moderna Inc.’s Covid-19 vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE. Jason Gale reports on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
Curated Video
Analyst: Antibodies don't always mean virus immunity
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
Press Association
Blood plasma donations begin in Twickenham for 'lifesaving' medicines after 20 year ban
People donate blood plasma in Twickenham for use in the manufacture of “lifesaving” medicines. It comes after the lifting of a ban lasting more than two decades.
Donor Martin Rengger is assisted by donor care supervisor Gregory Wasik....
Bloomberg
Centivax Antibodies Aim to Combat Covid-19 Variants: CEO
Jan.25 -- Centivax CEO Jacob Glanville discusses the company’s antibody treatment for Covid-19 with the goal of making the pandemic a “manageable infectious disease.” He speaks with Bloomberg’s David Westin on "Bloomberg Markets:...
Bloomberg
Ebola in New York City: How Worried Should You Be?
Oct. 24 -- Dr. Stephen Morse, a professor of epidemiology at Columbia University, explains why New Yorkers shouldn't be too worried about Ebola. He speaks with Bloomberg's Emily Chang on ""Bloomberg West."" (Source: Bloomberg)
Bloomberg
Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Bloomberg
Wuxi Biologics: Covid-19 Antibody Products Out By Year End
Aug.18 -- Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg...
Curated Video
Analyst: Antibodies don't always mean virus immunity
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
Bloomberg
Coronavirus Treatment: Antibodies and the Race for a Vaccine
May.04 -- Takeda President of Global Business Rajeev Venkayya discusses efforts among companies and nations to develop a coronavirus vaccine and the importance of making the vaccine available to the entire world. He speaks on "Bloomberg...
Bloomberg
Johns Hopkins’ Sauer: ‘A Lot of Work to Be Done’ on Covid-19 Antibodies
May.27 -- Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses what is being learned about Covid-19 from testing data and studies on potential treatments. She speaks on "Bloomberg Surveillance." The Bloomberg...
Press Association
Interview with Professor Roberts encourages plasma donations
Interview with Professor David Roberts on new plasma trials for the NHS to help fight coronavirus, as they call for more volunteers to come forward to donate.
Bloomberg
Covid-19 Causes Broad Spectrum of Diseases: Johns Hopkins’ Pekosz
Apr.17 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz explains what is being learned about patterns of coronavirus infections, the uncertainties of testing, and questions about immunity and reinfection. He...
Press Association
Ex-firefighter makes 10th Covid-19 plasma donation
A former firefighter from Birmingham has become the first person in England to make 10 donations of convalescent plasma for the fight against Covid-19. Stephen Franklin, 54, had the virus in March and began donating in April.
Bloomberg
Unlikely Vaccine Efficacy Drops to Zero: Johns Hopkins
Johns Hopkins Center for Health Security Senior Scholar Gigi Gronvall discusses the use of existing vaccines to combat the omicron variant and the logistics of travel bans and testing. The Bloomberg School of Public Health is supported...
Curated Video
COVID Antibody Treatments Sit Unused, May Not Work For New Variants
In parts of the country large amounts of the treatment are sitting unused.
Bloomberg
Covid Boosters Will Absolutely Be Needed: Johns Hopkins’ Hansoti
Sep.01 -- Johns Hopkins University Associate Professor of Emergency Medicine Bhakti Hansoti discusses antibodies created by Covid-19 vaccines and the need for booster shots. The Bloomberg School of Public Health is supported by Michael...
Curated Video
Hospitals Brace For Impact Of New Variant While Still Handling Delta
Hospitals across the country have been hit with staff shortages and ICU overflows.
Curated Video
Newsy's Latest Health News
Eli Lilly will start testing an experimental drug on coronavirus patients. One in five NY residents tested positive for antibodies to the coronavirus.
Curated Video
Pfizer, NYU Developing COVID-19 Vaccine With Hopeful September Release
Researchers are trying to build a vaccine that uses messenger RNA to help the human body produce antibodies.
Curated Video
Newsy's Latest Headlines
U.S. unemployment hits 33 million, Neiman Marcus files for bankruptcy and new study says people who contract COVID-19 eventually create antibodies.
Bloomberg
Lilly Aims to Produce 100K Covid-19 Antibody Doses by Year End: CFO
Jul.30 -- Eli Lilly Chief Financial Officer Joshua Smiley says the drugmaker expects to start registratrion trials of its coronavirus antibody treatment "within the next few weeks" and to produce 100,000 doses of a successful therapeutic...